KEGG pathways enriched in the hyper-mCpH enhancers included immune-related diseases and pathways, such as inflammatory bowel disease (hsa05321), intestinal immune network for IgA production (hsa04672), and virus infections (hsa05164 and hsa05168) (Fig. 4b). This evidence concerns the gene CD79A and inflammatory bowel disease.